Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-21-000006

Options or other derivatives

  • CEO acquired 26,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-26 Grant or award : show line 1 in the form Stock Options +26,000 56,001 D
Loading xslF345X03/primary_doc.xml…